Knowledge Hub

Deep dives for pharma professionals

Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.

141 articles in the hub
How Anti-CD8 Alpha Antibody Helps in Determining Failure of a TreatmentResearch

How Anti-CD8 Alpha Antibody Helps in Determining Failure of a Treatment

Discover how anti-CD8 Alpha antibody helps researchers track T-cell response in immunotherapy and cancer diagnostics.

Team Pharma NowApr 14, 2026
Computer System Validator (CSV) vs. Computer System Assurance (CSA): What Are the Main Differences?Research

Computer System Validator (CSV) vs. Computer System Assurance (CSA): What Are the Main Differences?

Guide to Computer System Validation (CSV) vs Computer Software Assurance (CSA) in pharma with key differences and risk-based approach.

Vaibhavi M.Apr 10, 2026
Preclinical Screening Of Antihypertensive Agents: A Detailed Guide For Pharma ProfessionalsInnovation

Preclinical Screening Of Antihypertensive Agents: A Detailed Guide For Pharma Professionals

A detailed guide to preclinical screening of antihypertensive agents for pharma professionals.

Vaibhavi M.Feb 16, 2026
6 Cost Pressures Quietly Eroding Pharma Profit Margins & How Leaders Are RespondingMarket Trends

6 Cost Pressures Quietly Eroding Pharma Profit Margins & How Leaders Are Responding

Six hidden cost pressures squeezing pharma margins and how leaders are protecting profitability in 2026.

Simantini Singh DeoFeb 16, 2026
7 Ways Rising Regulatory Pressure Is Reshaping Pharma Manufacturing EconomicsMarket Trends

7 Ways Rising Regulatory Pressure Is Reshaping Pharma Manufacturing Economics

How rising regulatory pressure is transforming cost structures and strategy in pharma manufacturing.

Simantini Singh DeoFeb 16, 2026
PROTACs and Molecular Glues: How Targeted Protein Degradation Is Redefining Drug DiscoveryResearch

PROTACs and Molecular Glues: How Targeted Protein Degradation Is Redefining Drug Discovery

How PROTACs and molecular glues are redefining drug discovery through targeted protein degradation strategies.

Mrudula KulkarniFeb 13, 2026
Neuroinflammation As A Target Class: The New Frontier In CNS Drug DevelopmentResearch

Neuroinflammation As A Target Class: The New Frontier In CNS Drug Development

Why neuroinflammation is emerging as a major target class reshaping CNS drug development and neurology research.

Vaibhavi M.Feb 13, 2026
Senolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of AgeingResearch

Senolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing

How senolytics and microbiome modifiers are reshaping ageing biology by targeting inflammation, senescence, and system-level decline.

Mrudula KulkarniFeb 12, 2026
Psychedelic-Assisted Therapies: How Science Is Re-Exploring A Controversial Class Of MedicinesResearch

Psychedelic-Assisted Therapies: How Science Is Re-Exploring A Controversial Class Of Medicines

How psychedelic-assisted therapies are being re-explored to treat depression, PTSD, and addiction through science-led care.

Vaibhavi M.Feb 12, 2026
Live Biotherapeutic Products: The Future of Microbiome-Based MedicineInnovation

Live Biotherapeutic Products: The Future of Microbiome-Based Medicine

A deep dive into the clinical development, safety considerations, and commercial future of live biotherapeutic products.

Vaibhavi M.Jan 27, 2026
Engineered Microbes for APIsResearch

Engineered Microbes for APIs

How engineered microbes are quietly reshaping API manufacturing through biology, fermentation, and smarter, more resilient pharma production.

Mrudula KulkarniJan 27, 2026
How Granulation Bottlenecks Are Silently Eating Into Pharma Margins?Innovation

How Granulation Bottlenecks Are Silently Eating Into Pharma Margins?

Granulation bottlenecks rarely cause failures, but they quietly reduce throughput, inflate costs, and erode margins in pharma manufacturing.

Mrudula KulkarniJan 21, 2026